These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 34337882)

  • 1. Association of systemic inflammation with survival in patients with cancer cachexia: results from a multicentre cohort study.
    Zhang Q; Song MM; Zhang X; Ding JS; Ruan GT; Zhang XW; Liu T; Yang M; Ge YZ; Tang M; Li XR; Qian L; Song CH; Xu HX; Shi HP
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1466-1476. PubMed ID: 34337882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic effect of hemoglobin on patients with cancer cachexia: a multicenter retrospective cohort study.
    Zhang XW; Zhang Q; Song MM; Zhang KP; Zhang X; Ruan GT; Yang M; Ge YZ; Tang M; Li XR; Wang KH; Shi HP
    Support Care Cancer; 2022 Jan; 30(1):875-885. PubMed ID: 34392426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geriatric Nutrition Risk Index: Prognostic factor related to inflammation in elderly patients with cancer cachexia.
    Ruan GT; Zhang Q; Zhang X; Tang M; Song MM; Zhang XW; Li XR; Zhang KP; Ge YZ; Yang M; Li QQ; Chen YB; Yu KY; Cong MH; Li W; Wang KH; Shi HP
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1969-1982. PubMed ID: 34585849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of the combination of body composition and systemic inflammation in patients with cancer cachexia.
    Xie HL; Ruan GT; Wei L; Zhang Q; Ge YZ; Song MM; Zhang X; Lin SQ; Liu XY; Zhang XW; Li XR; Zhang KP; Hu CL; Yang M; Tang M; Song CH; Cong MH; Weng M; Li ZN; Li W; Wang KH; Shi HP
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):879-890. PubMed ID: 36872512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triceps skinfold-albumin index significantly predicts the prognosis of cancer cachexia: A multicentre cohort study.
    Yin L; Cui J; Lin X; Li L; Li N; Fan Y; Zhang L; Liu J; Chong F; Lu Z; Wang C; Liang T; Liu X; Deng L; Yang M; Yu J; Wang X; Cong M; Li Z; Weng M; Yao Q; Jia P; Guo Z; Li W; Song C; Shi H; Xu H
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):517-533. PubMed ID: 36567070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer.
    Demirelli B; Babacan NA; Ercelep Ö; Öztürk MA; Kaya S; Tanrıkulu E; Khalil S; Hasanov R; Alan Ö; Telli TA; Koca S; Arıbal ME; Kuzan B; Dane F; Yumuk PF
    Nutr Cancer; 2021; 73(2):230-238. PubMed ID: 32270713
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer.
    Derman BA; Macklis JN; Azeem MS; Sayidine S; Basu S; Batus M; Esmail F; Borgia JA; Bonomi P; Fidler MJ
    BMC Cancer; 2017 Feb; 17(1):141. PubMed ID: 28209123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Systemic Inflammation and Malnutrition With Survival in Nasopharyngeal Carcinoma Undergoing Chemoradiotherapy: Results From a Multicenter Cohort Study.
    Wang X; Yang M; Ge Y; Tang M; Rao B; Chen Y; Xu H; Cong M; Guo Z; Shi H
    Front Oncol; 2021; 11():766398. PubMed ID: 34765561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated neutrophil-to-lymphocyte ratio and handgrip strength better predict survival in patients with cancer cachexia.
    Zhang KL; Zhou MM; Wang KH; Weng M; Zhou FX; Cui JW; Li W; Ma H; Guo ZQ; Li SY; Chen JQ; Wu XH; Zhao QC; Li JP; Xu HX; Shi HP; Song CH
    Nutrition; 2024 Jun; 122():112399. PubMed ID: 38493542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of systemic inflammation and for patients with colorectal cancer cachexia.
    Ruan GT; Xie HL; Yuan KT; Lin SQ; Zhang HY; Liu CA; Shi JY; Ge YZ; Song MM; Hu CL; Zhang XW; Liu XY; Yang M; Wang KH; Zheng X; Chen Y; Hu W; Cong MH; Zhu LC; Deng L; Shi HP
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2813-2823. PubMed ID: 37902006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between LDH and GLIM criteria for cancer cachexia: Systematic review and meta-analysis.
    Thompson JJ; McGovern J; Roxburgh CSD; Edwards J; Dolan RD; McMillan DC
    Crit Rev Oncol Hematol; 2024 Jul; 199():104378. PubMed ID: 38754770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of low hand grip strength with 1 year mortality of cancer cachexia: a multicentre observational study.
    Song M; Zhang Q; Tang M; Zhang X; Ruan G; Zhang X; Zhang K; Ge Y; Yang M; Li Q; Li X; Liu X; Li W; Cong M; Wang K; Song C; Shi H
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1489-1500. PubMed ID: 34545711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships of emerging biomarkers of cancer cachexia with quality of life, appetite, and cachexia.
    Lipshitz M; Visser J; Anderson R; Nel DG; Smit T; Steel HC; Rapoport BL
    Support Care Cancer; 2024 May; 32(6):349. PubMed ID: 38744744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From the C SCANS Study.
    Feliciano EMC; Kroenke CH; Meyerhardt JA; Prado CM; Bradshaw PT; Kwan ML; Xiao J; Alexeeff S; Corley D; Weltzien E; Castillo AL; Caan BJ
    JAMA Oncol; 2017 Dec; 3(12):e172319. PubMed ID: 28796857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum total bilirubin with survival outcomes in patients with cancer cachexia: A prospective, multicenter cohort study.
    Li XR; Zhang Q; Zhang KP; Zhang X; Ruan GT; Song MM; Ge YZ; Zhang XW; Song CH; Shi HP
    Nutrition; 2022 Oct; 102():111711. PubMed ID: 35810575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Optimal Threshold of Neutrophil-Lymphocyte Ratio and Its Association With Survival Outcomes Among Patients With Head and Neck Cancer.
    Ma SJ; Yu H; Khan M; Gill J; Santhosh S; Chatterjee U; Iovoli A; Farrugia M; Mohammadpour H; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Hicks WL; Platek ME; Seshadri M; Ray AD; Repasky E; Singh AK
    JAMA Netw Open; 2022 Apr; 5(4):e227567. PubMed ID: 35426920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AWGC2023 cachexia consensus as a valuable tool for predicting prognosis and burden in Chinese patients with cancer.
    Xie H; Wei L; Ruan G; Zhang H; Shi J; Lin S; Liu C; Liu X; Zheng X; Chen Y; Chen J; Shi H
    J Cachexia Sarcopenia Muscle; 2024 Oct; 15(5):2084-2093. PubMed ID: 39192568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers.
    Li M; Spakowicz D; Burkart J; Patel S; Husain M; He K; Bertino EM; Shields PG; Carbone DP; Verschraegen CF; Presley CJ; Otterson GA; Kendra K; Owen DH
    J Cancer Res Clin Oncol; 2019 Oct; 145(10):2541-2546. PubMed ID: 31367835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life but not cachexia definitions are associated with overall survival in women with cervical cancer: a STROBE-compliant cohort study.
    Luvián-Morales J; Delgadillo-González M; Castro-Eguiluz D; Oñate-Ocaña LF; Cetina-Pérez L
    Jpn J Clin Oncol; 2024 Apr; 54(4):416-423. PubMed ID: 38146122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.